AAIRF
OTCM
Market cap2mUSD
Nov 19, Last price
0.02USD
1D
-29.72%
1Q
-50.15%
IPO
-96.52%
Name
American Aires Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
American Aires Inc. is a nanotechnology company, established in 2012 and headquartered in Vaughan, Canada. The firm focuses on the research, development, manufacturing, and distribution of its own silicon-based microprocessors, which are sold in Canada to protect people from the detrimental effects of electromagnetic radiation (EMR) produced by electronic devices. Its product lineup features the Aires Shield Pro, designed to lessen EMR from a wide array of personal and household electronics, including smartphones, tablets, computers, and Wi-Fi routers. For personal defense against ambient EMR, the Aires Defender Pro helps protect wearers from sources like power lines and cell phone towers. Furthermore, the Aires Guardian provides EMR reduction within small areas. The company also offers the Lifetune series—Lifetune Personal, Lifetune Pet, and Lifetune Room—which extends EMR protection to individuals, pets, and various spaces. These solutions shield against radiation from close-proximity electronic devices and the general "electromagnetic smog" created by data-transmitting equipment found in domestic, professional, or automotive settings.
Headquarters & legal address
40 King St West, suite 1700
Toronto, Ontario
Toronto, ON M4V 1X3
CA
Toronto, Ontario
Toronto, ON M4V 1X3
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||